Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Revolution Medicines, Inc.
organization4 mentionslast seen Oct 30, 2026
Biopharmaceutical company that developed RASONQUE for metastatic pancreatic adenocarcinoma.
Relationships 7
- Revolution Medicines, Inc.developsRASONQUE99% confidence3 sources
- Revolution Medicines, Inc.developspan-KRAS drug discovery99% confidence2 sources
- Revolution Medicines, Inc.employsYang Liu99% confidence2 sources
- Revolution Medicines, Inc.employsKristof Pota99% confidence2 sources
- Medicilonpartners withRevolution Medicines, Inc.99% confidence2 sources
- Revolution Medicines, Inc.employsMark A. Goldsmith97% confidence1 source
- Revolution Medicines, Inc.developszoldonrasib75% confidence1 source
Relationship
Medicilonpartners withRevolution Medicines, Inc.
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 30, 2026Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
Medicilon presented Revolution Medicines with the "Excellence in Client Partnership Award," recognizing the substantial clinical value of the company's pioneering pan-KRAS drug discovery and development
- newsPR NewswireOct 30, 2026Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
years of joint effort, mutual trust, and shared success by both R&D teams, setting an outstanding example of bilateral collaboration